Not logged in
  Home   Markets   Shares   Funds   Portfolio   Toolbox   Charting   Alerts   Directory   
 Admin   

Thu 25 Oct 2007, 16:28 WLL - Wellco - Detailed cautionary in respect of t
WLL
 WLL                                                                             
WLL - Wellco - Detailed cautionary in respect of the restructuring of the       
              company                                                           
WELLCO HEALTH LIMITED                                                           
(Incorporated in the Republic of South Africa)                                  
(Registration number 2005/005805/06)                                            
("Wellco" or "the company")                                                     
ISIN Code: ZAE000071841        Share code: WLL                                  
DETAILED CAUTIONARY ANNOUNCEMENT IN RESPECT OF THE RESTRUCTURING OF THE COMPANY 
1    Introduction                                                               
Shareholders are advised that the board of directors of Wellco has entered into 
a restructuring agreement with Arcay Merchant (Proprietary) Limited ("Arcay")   
dated 24 October 2007, which agreement is effective immediately.  The           
restructuring agreement provides, inter alia, for the appointment of a new      
management team, the appointment and resignation of directors, an agreed        
valuation of the company on which all transactions contemplated in the agreement
will be based, the recapitalisation of the company, the reversal of the recent  
licence agreement entered into by the outgoing board of directors and the agreed
disposal by the company of the Nutrimax brand (together referred to as the      
"Transaction").                                                                 
2    Appointment of a New Management Team and Restructuring of the Board of     
    Directors                                                                   
Michael Allan will be appointed as the Chief Executive Officer, Carol Ansara and
Linda Cameron will be appointed as executive directors with immediate effect,   
whilst Norman Preston and Tony McKeever have resigned from the board with       
immediate effect.  Dean Marais will continue to act as a director until 31      
December 2007 in order to facilitate a smooth handover to the incoming board.   
The curricula vitaes of the newly appointed directors are set out below:        
Michael Allan                                                                   
Qualifications:  BCom, ACMA                                                     
Past Employment:  Mike joined a multi-national brand company in 1987 as an      
accountant and was promoted to Financial Director following a career in South   
Africa and Europe. Prior to joining the Arcay Consortium, Mike successfully     
formed a new franchise division under a leading brand to enhance and expand the 
product range.                                                                  
Mike`s particular interest lies in building and managing the infrastructures    
that support a portfolio of brands.                                             
Carol Ansara                                                                    
Qualifications:  B. Com, BCom Hons (Econ)                                       
Past Employment:  Carol joined a multi-national brand company in 1989 and worked
in various brand and marketing management positions culminating in a marketing  
director of a number of leading brands.    Carol`s last brief as Director was to
develop a franchise business plan and nationally launch a new division under a  
leading brand.                                                                  
Carol`s key strength lies in managing a portfolio of brands whilst exploiting   
their full potential.                                                           
Linda Cameron                                                                   
Qualifications: B. Com, B. Com (Hons), CA (SA)                                  
Past Employment: Linda completed her articles at Grant Thornton and was         
thereafter seconded to Grant Thornton`s London office for a 5-month period.     
Linda joined Imagine Wealth in September 2004 and is responsible for a variety  
of financial management functions in both the listed and unlisted arena for     
Imagine Wealth`s clients.                                                       
3    Rationale                                                                  
Whilst the Transaction has been entered into as a rescue operation, it provides 
Wellco with a strong new management team with extensive brand management        
experience, capable of rebuilding the company and rapidly expanding its         
operations.  The Restructured Board believes that provided that suitable        
settlement arrangements can quickly be reached with the company`s existing      
creditors, it will be in a position to rebuild the company`s brands and acquire 
significant other complimentary brands.                                         
4    Valuation                                                                  
The parties have agreed that for purposes of the Transaction, a value of 3.5    
cents per share has been placed on the company`s shares.                        
5    Recapitalisation of the Company                                            
As advised by the outgoing board in the commentary to the audited consolidated  
results for the year ended 28 February 2007 ("the Results Announcement"), the   
company requires an injection of capital in order to cover working capital      
requirements, negotiate and settle with creditors and fund the cash flow        
requirements to restructure and grow the company.  The new board of directors   
proposes to raise the requisite capital by means of a share placement with      
strategic partners and a rights offer to existing shareholders.  Details of the 
proposed recapitalisation plan will be announced on SENS in due course.         
6    Future Strategy                                                            
The new management will focus on the organic growth of Wellco`s existing brand  
portfolio, brand extension opportunities and strategic acquisition              
opportunities.                                                                  
7    Reversal of Licence Agreement                                              
The licence agreement entered into with a major distributor on a set royalty    
fee, as disclosed in the Results Announcement will be cancelled and the company 
will regain full control over the Herbology brand.                              
8    Disposal of Nutrimax Brand                                                 
The newly appointed board will request shareholders to approve the sale of the  
Nutrimax brand for a purchase consideration of R3.8 million, as disclosed in the
Results Announcement.                                                           
9    Rescue Operation                                                           
The Restructured Board will make application to the JSE Limited ("the JSE") to  
have the Transaction declared as a rescue operation for purposes of expediting  
the Recapitalisation of the Company and the disposal of the Nutrimax brand.  The
results of this application will be released on SENS in due course.             
10   Financial Effects                                                          
The financial effects of the Transaction will be announced following            
negotiations with creditors and the finalisation of the proposals relating to   
the recapitalisation of the company.                                            
11   Conditions Precedent                                                       
The Transaction remains subject to conditions precedent usually associated with 
a transaction of this nature including the approval of the requisite regulatory 
authorities, including the JSE and the Securities Regulation Panel ("SRP") and  
the approval of the requisite majority of Wellco shareholders at a meeting      
convened for the purpose of approving the requisite resolutions relating to,    
inter alia, the Recapitalisation of the Company and the Disposal of the Nutrimax
Brand.                                                                          
12   Appointment of new Designated Advisor                                      
Arcay Moela Sponsors (Pty) Ltd has been appointed as the Designated Advisor to  
the company with immediate effect.                                              
13   Appointment of new Company Secretary                                       
Arcay Client Support (Pty) has been appointed as Company Secretary with         
immediate effect.                                                               
14   Cautionary Announcement                                                    
Shareholders are advised that the full impact and the related financial effects 
of the proposed restructuring remains to be determined, but is expected to have 
a material effect on the price of the company`s securities.  Shareholders are   
accordingly advised to exercise caution when dealing in the company`s securities
until a full announcement is made.                                              
Johannesburg                                                                    
25 October 2007                                                                 
Corporate Advisor to Arcay              Designated Advisor                      
Arcay Corporate Finance (Pty) Ltd       Arcay Moela Sponsors (Pty) Ltd          
                                                                                
Date: 25/10/2007 16:28:30 Produced by the JSE SENS Department.                  
The SENS service is an information dissemination service administered by the    
JSE Limited (`JSE`). The JSE does not, whether expressly, tacitly or            
implicitly, represent, warrant or in any way guarantee the truth, accuracy or   
completeness of the information published on SENS. The JSE, their officers,     
employees and agents accept no liability for (or in respect of) any direct,     
indirect, incidental or consequential loss or damage of any kind or nature,     
howsoever arising, from the use of SENS or the use of, or reliance on,          
information disseminated through SENS.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
Other Profile Group sites: FundsData Online (unit trust data)  |  Profile Group corporate site
[  Terms of Use |  Privacy Policy |  PAIA manual |  FAQs/Help |  Site Map |  © Copyright Reserved 2026  ]
  


Powered by ProfileData

Profile Mobile App Google Play Store Apple App Store


Follow us on: